Fintel reports that on December 5, 2025, Morgan Stanley maintained coverage of Vertex Pharmaceuticals (NasdaqGS:VRTX) with a ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently, Vertex Pharmaceuticals ...

It has been about a month since the last earnings report for Adma Biologics (ADMA). Shares have added about 43.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Praxis Precision Medicines, Inc. soars after study success and pipeline wins. Explore key milestones, projections, and ...